Affiance Financial’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $233K | Hold |
2,979
| – | – | 0.03% | 104 |
|
|
2026
Q1 | $258K | Hold |
2,979
| – | – | 0.04% | 96 |
|
|
2025
Q4 | $286K | Sell |
2,979
-53
| -2% | -$5.15K | 0.05% | 91 |
|
|
2025
Q3 | $289K | Sell |
3,032
-42
| -1% | -$3.86K | 0.05% | 89 |
|
|
2025
Q2 | $268K | Hold |
3,074
| – | – | 0.05% | 87 |
|
|
2025
Q1 | $276K | Sell |
3,074
-799
| -21% | -$71.5K | 0.06% | 89 |
|
|
2024
Q4 | $309K | Buy |
3,873
+700
| +22% | +$60.6K | 0.07% | 83 |
|
|
2024
Q3 | $286K | Hold |
3,173
| – | – | 0.07% | 86 |
|
|
2024
Q2 | $250K | Hold |
3,173
| – | – | 0.07% | 85 |
|
|
2024
Q1 | $277K | Sell |
3,173
-1,231
| -28% | -$105K | 0.07% | 84 |
|
|
2023
Q4 | $363K | Sell |
4,404
-2,413
| -35% | -$184K | 0.11% | 78 |
|
|
2023
Q3 | $534K | Hold |
6,817
| – | – | 0.27% | 61 |
|
|
2023
Q2 | $601K | Hold |
6,817
| – | – | 0.29% | 60 |
|
|
2023
Q1 | $550K | Hold |
6,817
| – | – | 0.29% | 58 |
|
|
2022
Q4 | $530K | Sell |
6,817
-1,280
| -16% | -$104K | 0.21% | 68 |
|
|
2022
Q3 | $654K | Buy |
8,097
+99
| +1% | +$8.9K | 0.37% | 40 |
|
|
2022
Q2 | $718K | Hold |
7,998
| – | – | 0.39% | 42 |
|
|
2022
Q1 | $887K | Hold |
7,998
| – | – | 0.43% | 38 |
|
|
2021
Q4 | $827K | Sell |
7,998
-168
| -2% | -$19.5K | 0.35% | 47 |
|
|
2021
Q3 | $1.02M | Hold |
8,166
| – | – | 0.45% | 42 |
|
|
2021
Q2 | $1.01M | Hold |
8,166
| – | – | 0.43% | 42 |
|
|
2021
Q1 | $965K | Sell |
8,166
-27
| -0.3% | -$3.16K | 0.43% | 42 |
|
|
2020
Q4 | $960K | Buy |
8,193
+400
| +5% | +$44K | 0.5% | 37 |
|
|
2020
Q3 | $810K | Hold |
7,793
| – | – | 0.47% | 41 |
|
|
2020
Q2 | $715K | Hold |
7,793
| – | – | 0.39% | 41 |
|
|
2020
Q1 | $703K | Hold |
7,793
| – | – | 0.48% | 38 |
|
|
2019
Q4 | $884K | Sell |
7,793
-281
| -3% | -$30.8K | 0.49% | 35 |
|
|
2019
Q3 | $877K | Buy |
8,074
+102
| +1% | +$10.6K | 0.53% | 36 |
|
|
2019
Q2 | $776K | Sell |
7,972
-235
| -3% | -$21.5K | 0.47% | 42 |
|
|
2019
Q1 | $747K | Hold |
8,207
| – | – | 0.47% | 42 |
|
|
2018
Q4 | $747K | Sell |
8,207
-588
| -7% | -$54.9K | 0.49% | 43 |
|
|
2018
Q3 | $865K | Buy |
8,795
+715
| +9% | +$66.1K | 0.57% | 35 |
|
|
2018
Q2 | $692K | Buy |
8,080
+1,268
| +19% | +$106K | 0.53% | 42 |
|
|
2018
Q1 | $546K | Sell |
6,812
-1,445
| -18% | -$119K | 0.48% | 41 |
|
|
2017
Q4 | $667K | Buy |
8,257
+40
| +0.5% | +$3.2K | 0.49% | 33 |
|
|
2017
Q3 | $639K | Sell |
8,217
-40
| -0.5% | -$3.32K | 0.51% | 33 |
|
|
2017
Q2 | $733K | Sell |
8,257
-1,076
| -12% | -$90.7K | 0.58% | 29 |
|
|
2017
Q1 | $752K | Sell |
9,333
-1,209
| -11% | -$94.4K | 0.58% | 31 |
|
|
2016
Q4 | $751K | Buy |
10,542
+254
| +2% | +$20K | 0.6% | 33 |
|
|
2016
Q3 | $889K | Hold |
10,288
| – | – | 0.72% | 25 |
|
|
2016
Q2 | $893K | Buy |
10,288
+2,154
| +26% | +$174K | 0.76% | 25 |
|
|
2016
Q1 | $610K | Sell |
8,134
-395
| -5% | -$29.8K | 0.58% | 36 |
|
|
2015
Q4 | $656K | Sell |
8,529
-144
| -2% | -$10.8K | 0.67% | 34 |
|
|
2015
Q3 | $581K | Buy |
8,673
+148
| +2% | +$10.9K | 0.73% | 39 |
|
|
2015
Q2 | $632K | Sell |
8,525
-738
| -8% | -$56.4K | 0.81% | 34 |
|
|
2015
Q1 | $722K | Buy |
+9,263
| New | +$702K | 1.1% | 24 |
|
Other funds holding MDT
FWIA
GAM
SRIM
DC
Affiance Financial's MDT Position: Q2 2026 in Review
Affiance Financial held its Medtronic (MDT) position steady in Q2 2026 at 2,979 shares worth $233K. The position accounts for 0.03% of the portfolio, ranked #104.
Affiance Financial first reported a position in MDT in Q1 2015 and has held it in 46 quarters since. The position peaked at $1.02M in Q3 2021. 947 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Affiance Financial held 2,979 shares of Medtronic worth $233K as of Q2 2026.
- Affiance Financial left its Medtronic share count unchanged in Q2 2026.
- Medtronic made up 0.03% of Affiance Financial's portfolio in Q2 2026, its #104 holding.
- Affiance Financial first reported a position in Medtronic in Q1 2015 and has held it in 46 quarters since.
- Affiance Financial's Medtronic position peaked at $1.02M in Q3 2021.
- 947 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Affiance Financial's 13F filing for Q2 2026, filed 9 Jul 2026.